Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 3
2006 4
2007 1
2008 1
2009 6
2010 6
2011 2
2012 4
2013 5
2014 3
2015 4
2016 3
2017 8
2018 3
2019 2
2020 3
2021 6
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Effects of azithromycin and doxycycline on the vaginal microbiota of women with urogenital Chlamydia trachomatis infection: a substudy of the Chlazidoxy randomized controlled trial.
Tamarelle J, Penaud B, Tyssandier B, Guichoux E, de Barbeyrac B, Peuchant O; Chlazidoxy study group. Tamarelle J, et al. Among authors: de barbeyrac b. Clin Microbiol Infect. 2023 Aug;29(8):1056-1062. doi: 10.1016/j.cmi.2023.04.020. Epub 2023 Apr 24. Clin Microbiol Infect. 2023. PMID: 37100225 Clinical Trial.
Multi-component prime-boost Chlamydia trachomatis vaccination regimes induce antibody and T cell responses and accelerate clearance of infection in a non-human primate model.
Lorenzen E, Contreras V, Olsen AW, Andersen P, Desjardins D, Rosenkrands I, Juel HB, Delache B, Langlois S, Delaugerre C, Joubert C, Dereuddre-Bosquet N, Bébéar C, De Barbeyrac B, Touati A, McKay PF, Shattock RJ, Le Grand R, Follmann F, Dietrich J. Lorenzen E, et al. Among authors: de barbeyrac b. Front Immunol. 2022 Nov 23;13:1057375. doi: 10.3389/fimmu.2022.1057375. eCollection 2022. Front Immunol. 2022. PMID: 36505459 Free PMC article.
Doxycycline versus azithromycin for the treatment of anorectal Chlamydia trachomatis infection in women concurrent with vaginal infection (CHLAZIDOXY study): a multicentre, open-label, randomised, controlled, superiority trial.
Peuchant O, Lhomme E, Martinet P, Grob A, Baïta D, Bernier C, Gibaud SA, Le Hen I, Le Naour E, Trignol-Viguier N, Lanotte P, Lefebvre P, Vachée A, Girard T, Loubinoux J, Bébéar C, Ghezzoul B, Roussillon C, Kret M, de Barbeyrac B; CHLAZIDOXY Study Group. Peuchant O, et al. Among authors: de barbeyrac b. Lancet Infect Dis. 2022 Aug;22(8):1221-1230. doi: 10.1016/S1473-3099(22)00148-7. Epub 2022 May 9. Lancet Infect Dis. 2022. PMID: 35550262 Clinical Trial.
Ongoing evolution of Chlamydia trachomatis lymphogranuloma venereum: exploring the genomic diversity of circulating strains.
Seth-Smith HMB, Bénard A, Bruisten SM, Versteeg B, Herrmann B, Kok J, Carter I, Peuchant O, Bébéar C, Lewis DA, Puerta T, Keše D, Balla E, Zákoucká H, Rob F, Morré SA, de Barbeyrac B, Galán JC, de Vries HJC, Thomson NR, Goldenberger D, Egli A. Seth-Smith HMB, et al. Among authors: de barbeyrac b. Microb Genom. 2021 Jun;7(6):000599. doi: 10.1099/mgen.0.000599. Microb Genom. 2021. PMID: 34184981 Free PMC article.
Identification of 16S rRNA mutations in Mycoplasma genitalium potentially associated with tetracycline resistance in vivo but not selected in vitro in M. genitalium and Chlamydia trachomatis.
Le Roy C, Touati A, Balcon C, Garraud J, Molina JM, Berçot B, de Barbeyrac B, Pereyre S, Peuchant O, Bébéar C. Le Roy C, et al. Among authors: de barbeyrac b. J Antimicrob Chemother. 2021 Apr 13;76(5):1150-1154. doi: 10.1093/jac/dkab016. J Antimicrob Chemother. 2021. PMID: 33537731
63 results